Knobbe/Martens: Intellectual Property Law
Developing IP strategies aimed at furthering my client’s business goals is my constant focus.

Kerry S. Taylor, Ph.D.

Partner

At a Glance

  • J.D. University of California - Berkeley School of Law
  • Ph.D. Biochemistry & Molecular Biology, University of Chicago
  • B.S. Chemistry, Wheaton College

  • State Bar of California
  • U.S. Patent and Trademark Office

Cases, Articles, Speeches & Seminars

Representative Matters

  • Illumina, Inc. v. Cornell Research Foundation, Inc., Case IPR2016-00557 (2017). Represented Illumina in an IPR proceeding challenging a patent relating to assays for DNA detection. Achieved favorable case-dispositive settlement for client after institution of the IPR.
  • Intelligent Bio-Systems, Inc. v. Illumina Cambridge Ltd., 821 F.3d 1359 (Fed. Cir. 2016). Represented Illumina and obtained affirmance of IPR final written decision upholding the validity of all challenged claims from a patent directed to DNA sequencing-by-synthesis.
  • Ariosa Diagnostics, Inc. v. Illumina, Inc., Case IPR2014-01093 (2016). Represented Illumina in an IPR proceeding defending a patent directed to noninvasive prenatal screening methods.  Obtained final written decision upholding the validity of all challenged claims.
  • Roche Molecular Systems Inc. v. Illumina, Inc., Case IPR2015-01091 (2015). Defended Illumina against a petition for IPR regarding a patent for noninvasive prenatal screening methods.  Obtained decision denying petition and rejecting all challenges raised against Illumina’s claims.
  • Intelligent Bio-Systems, Inc. v. Illumina Cambridge Ltd., Case IPR2013-00517 (2015). Represented Illumina in an IPR proceeding defending a patent directed to DNA sequencing-by-synthesis.  Obtained final written decision upholding the validity of all challenged claims.
  • BioGatekeeper, Inc. v. Kyoto University, Case IPR2014-01286 (2015). Represented Kyoto University against a petition for IPR regarding a patent co-invented by Nobel Prize laureate Professor Shinya Yamanaka directed to induced pluripotent stem cells.  Obtained decision denying petition and rejecting the challenge raised against Kyoto University's patent.
  • Ranbaxy Labs., Ltd. and Ranbaxy, Inc. v. Vertex Pharms., Inc., Case IPR2013-00024 (2013). Represented Ranbaxy in an IPR proceeding challenging a patent relating to fosamprenavir (the active ingredient in Lexiva®).  Achieved favorable case-dispositive settlement for client after institution of the IPR.

Articles, Speeches & Seminars

  • Presented on "Post-Grant Review in Japan" at the Japan Patent Attorneys Association (JPAA) in San Diego, CA (February 2018).
  • Kerry Taylor, Scott Seeley co-authored, Federal Circuit's Treatment of Alleged APA Violations at the PTABWestlaw Journal Intellectual Property (January 2018)
  • Kerry Taylor, Brent Babcok co-authored, "The continuing CRISPR patent battle: the Broad Institute loses a key European patentMedCity News (January 2018).
  • Kerry Taylor, Clayton Henson co-authored, "IPR Appeals in 2017: The Ouctomes Remand PTABLaw360 (January 2018).
  • Kerry Taylor, Daniel Kamkar, Joel Broussard co-authored, "IPR Appeals in 2017: The Pendency And Success Rates," Law360 (January 2018).
  • Peter Law, Kerry Taylor, "Allergan and the Saint Regis Mowhawk Tribe Enter Patent Agreement to Defend Against IPR of RESTATIS® Patents" The Licensing Journal (December 2017).
  • Moderated panel discussion on "PTAB:  A View From In-House" at the San Diego Intellectual Property meeting in San Diego, CA (November 2017).
  • Nathanael Luman, Kerry Taylor, "Can I Appeal my Inter Partes Review? The Federal Circuit Clarifies Article III Standing for Petitioners" National Institute for Trial Advocacy (September 2017).
  • Nathanael Luman, Kerry Taylor, "Five Techniques To Stop an IPR Before it Starts" Today's General Counsel (June 2017).
  • Nathanael Luman, Kerry Taylor, "AIA Trial Institution Rates Are Good News For Patent Owners" Law360 (May 2017).
  • Daniel Kamkar, Kerry Taylor, "IPR Appeals: Pendency And Success Rates At Fed. Circ." Law360 (February 2017).
  • Clayton Henson, Kerry Taylor, "IPR Appeals: Outcomes In Fed. Circ. Remands To PTAB" Law360 (February 2017).
  • Presented on "Inter Partes Review in the Life Sciences" at the BIOCOM Intellectual Property and Patent Law Committee Meeting in San Diego, CA (May 2016).
  • Presented on "Aftershocks of the AIA's Post Grant Proceedings: Its Advocates & Critics," at the Thomas Jefferson School of Law Intellectual Property Symposium in San Diego, CA (March 2016).
  • Presented on "The Evolving World of Biosimilars" at the University of Chicago Alumni Club of San Diego: Biotech Speaker Series (April 2015).
  • Presented on "Patent Trial and Appeal Board - Multi-Petition Challenges of a Patent" at the University of San Diego School of Law Fifth Annual Patent Law Conference in San Diego, CA (January 2015).
  • Presented on “Intellectual Property Seminar for Executives and IP Managers" in Tokyo, Japan (November 2013).
  • Presented on "Strategies for Taking Advantage of the America Invents Act, Resolving the Tension Between Patentable Subject Matter & Joint Infringement" in Tokyo, Japan (October 2012). 
  • K.S. Taylor, D. Chung, R.M. Garavito, N. Pagratis, D. Demirjian, M. Casadaban, “Preliminary crystallographic studies on a b-galactosidase from Thermus acquaticus” American Crystallographic Association Annual Meeting, 1991.
  • K.S. Taylor, M.-Z. Lou, T.-M. Chin, N.C. Yang, R.M. Garavito, “Structure of a de novo designed helical peptide” American Crystallographic Association Annual Meeting, 1995.
  • K.S. Taylor, M.-Z. Lou, T.-M. Chin, N.C. Yang, R.M. Garavito, “A Novel, Multilayer Structure of a Helical Peptide” Protein Science 5:414-421 (1996).
  • K. S. Taylor, TrafFix Devices, Inc. v. Marketing Displays, Inc., 17 BERKELEY TECH. L.J. 205 (2002).
  • Eric Furman, Kerry Taylor, "Approaching Intellectual Property Protection for Biotechnology Companies in an Increasingly Competitive Market - The Over-Arching Issues You Need to Know" Aspatore Books (US) 2006.
  • E.S. Furman and K.S. Taylor, “Approaching IP protection for biotechs in increasingly competitive market.” San Diego Daily Transcript (October 19, 2006).
Attorney Finder